Vimarsana
Biggest News Aggregation in the World

Daniel Almeida News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Almeida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Almeida Today - Breaking & Trending Today

When Oregon decriminalized drugs, things didn't go to plan - Vimarsana News

When Oregon decriminalized drugs, things didn't go to plan

Drug decriminalization was meant to end the war on drugs, but Oregon's failures mean US reformers should take a closer look at Portugal's drug laws.

Nouveau/NVK Driver Lands NIL Library Rewrite In Rust For Mesa 24.1 - Vimarsana News

Nouveau/NVK Driver Lands NIL Library Rewrite In Rust For Mesa 24.1

In addition to working on NOVA as a Rust-based, GSP-focused NVIDIA open-source kernel graphics driver being developed as the eventual successor to the existing Nouveau DRM kernel driver, over in user-space Mesa developers have begun landing a portion of their Nouveau/NVK driver library code rewritten in Rust.

Linux's V4L2 VP9 Codec Kernel Code Rewritten In Rust For Better Memory Safety - Vimarsana News

Linux's V4L2 VP9 Codec Kernel Code Rewritten In Rust For Better Memory Safety

Daniel Almeida with Collabora has posted a rewritten of the VP9 codec library code within the Linux kernel's Video 4 Linux 2 (V4L2) subsystem

Rust-Written Stateless Codec Drivers Make A Lot Of Sense - Vimarsana News

Rust-Written Stateless Codec Drivers Make A Lot Of Sense

When it comes to making use of the Rust programming language within the Linux kernel, one of the areas where it makes a lot of sense is for the video codec drivers given the amount of unknown/untrusted data submitted by user-space for video processing and it being a wide attack surface for bad actors

Azafaros' Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled - Vimarsana News

Azafaros' Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled

          Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolledTopline data from the study, exp...